Display Settings:

Format

Send to:

Choose Destination
    Vaccine. 2008 Sep 26;26(41):5315-20. Epub 2008 Aug 3.

    Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors.

    Source

    Department of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, United States. dsewell@smail.umaryland.edu

    Abstract

    We have shown that Listeria-based cancer vaccines inhibit the growth of transplanted tumors in a transgenic mouse model of immune tolerance where HPV-16 E7 is expressed in the thyroid gland. In this study we determine whether these vaccines are able to inhibit autochthonous tumor growth in this animal model. Mice treated with Listeria vaccines expressing E7 had significantly smaller thyroid tumors than did mice treated with controls and possessed higher numbers of antigen-specific CD8(+) T cells within the spleens, tumors, and peripheral blood. This study shows that Listeria-based vaccines are able to slow autochthonous tumor growth and break immunological tolerance.

    PMID:
    18680778
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2600657
    Free PMC Article

    Images from this publication.See all images (6) Free text

    Figure 5
    Figure 1
    Figure 4
    Figure 2
    Figure 3
    Figure 6

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk